Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of addition of 2-fucosyllactose to infant formula on growth and specific pathways of utilization by Bifidobacterium in healthy term infants

23 Sept 2022

Abstract excerpt

Oligosaccharides in human milk support healthviaintestinal microbiome. We studied effects of addition of 2-fucosyllactose (2′FL) to the infant formula on infant growth, occurrence of adverse events (AE), and infant microbiome, including expression of microbial genes that metabolize 2′FL. Our hypothesis was that while 2′FL would not affect growth, it would cause changes in microbiome metabolism. In a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breastfeeding Practices and Influences
Share to Child Nutrition and Water Access
Share to Infant Nutrition and Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36211486
DOI: 10.3389/fnut.2022.961526

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of addition of 2-fucosyllactose to infant formula on growth and specific pathways of utilization by Bifidobacterium in healthy term infantsPMID 36211486Read ↗

Term Infant Formula Supplemented with Human Milk Oligosaccharides (2′Fucosyllactose and Lacto‐N‐ neo tetraose) Shifts Stool Microbiota and Metabolic Signatures Closer to that of Breastfed InfantsSemantic proximity Read ↗

Bifidogenic Effect of 2′-Fucosyllactose (2′-FL) on the Gut Microbiome of Healthy Formula-Fed Infants: A Randomized Clinical TrialSemantic proximity Read ↗

Genomic analysis of cultivated infant microbiomes identifies Bifidobacterium 2’-fucosyllactose utilization can be facilitated by co-existing speciesSemantic proximity Read ↗

Genomic analysis of cultivated infant microbiomes identifies <i>Bifidobacterium</i> 2’-fucosyllactose utilization can be facilitated by co-existing speciesSemantic proximity Read ↗

Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensalSemantic proximity Read ↗

Breast milk-derived human milk oligosaccharides promote Bifidobacterium interactions within a single ecosystem.Semantic proximity Read ↗

Strain-specific strategies of 2′-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697Semantic proximity Read ↗

Linking human milk oligosaccharide metabolism and early life gut microbiota: bifidobacteria and beyondSemantic proximity Read ↗

Gut Microbiome Composition and Metabolic Capacity Differ by FUT2 Secretor Status in Exclusively Breastfed Infants.Semantic proximity Read ↗

Longitudinal changes of human milk oligosaccharides, breastmilk microbiome and infant gut microbiome are associated with maternal characteristicsSemantic proximity Read ↗

Mutualistic interactions between Escherichia coli and Bifidobacterium bifidum enable degradation of human milk oligosaccharides in healthy infantsSemantic proximity Read ↗

Selective human milk oligosaccharide utilization by members of the Bifidobacterium pseudocatenulatum taxonSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.